DENVER- Scientists are looking for non-invasive ways to detect lung cancer in order to reduce the number of patients diagnosed with an advanced stage of the disease. A multiple marker test in peripheral blood is one such way. In research performed at the IRST Biosciences Laboratory in Italy, researchers looked at blood from 100 healthy donors and blood from 100 patients with non-small cell lung cancer (NSCLC). By using a combination of four specific testing techniques, they could discriminate between healthy donors and NSCLC patients.
Paola Ulivi, researcher at IRST, a biosciences laboratory in Meldola, Italy, will share the latest on her research at an abstract session Thursday, July 26 at 8 a.m. in the Louvre I room at the Windsor Barra Hotel.
Ulivi is willing to do media interviews. The media is invited to attend all events with proper registration. All events will be simultaneously translated from English to Portuguese. To register, please visit the Media and Press page on the Conference website at www.lalca2012.org/media_press.
The 5th Latin American Conference on Lung Cancer will highlight the latest in lung cancer research and tobacco control. Nearly 1,000 medical professionals will gather at the conference to discuss the latest lung cancer research and treatment. Lung cancer kills more than 1.5 million people each year worldwide. It is also among the most challenging cancers to treat. Yet, there is excitement and hope, thanks to new advances which are improving the chances of better outcomes.
About the IASLC:
The International Association for the Study of Lung Cancer (IASLC) is the only global organization dedicated to the study of lung cancer. Founded in 1974, the association's membership includes more than 3,500 lung cancer specialists in 80 countries. To learn more about IASLC please visit www.iaslc.org.
AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.